Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04809363 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of CDPATH™ to Help Manage and Treat Crohn's Disease

Study acronym: COMPASS-CD
StatusActive, Not Recruiting
PhasePhase 4
SponsorTakeda
Started2021-06-25
View on ClinicalTrials.gov ↗
CDPATH™ is a tool to help predict the potential for developing Crohn's disease related complications in certain adult participants within 3 years. The main aim of the study is to explore the use of CDPATH™ to describe a participant's risk profile and to have discussions with their doctor about the potential path of their Crohn's disease. The number of visits will be decided by the study clinic according to their standard practice.

Amendment history 1 change detected by DataLookout

2026-07-24
notable
Primary completion pushed: 2026-07-20 → 2026-09-12
Trial Details
NCT Number NCT04809363
Lead Sponsor Takeda
Conditions Crohn's Disease
Enrollment 200 participants
Start Date 2021-06-25
Primary Completion 2026-09-12 (estimated)
Study Completion 2026-09-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-23